|
More AI
|
3
|
Resverlogix Corp.
|
Apr 08, 2020 10:40PM
|
|
Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
3
|
Resverlogix Corp.
|
Aug 04, 2020 08:36AM
|
|
Hepalink
|
4
|
Resverlogix Corp.
|
Jan 13, 2022 10:00PM
|
|
Re: Fair warning to everyone here....
|
4
|
Resverlogix Corp.
|
Jun 25, 2019 11:41AM
|
|
ACE2
|
4
|
Resverlogix Corp.
|
Sep 13, 2020 09:41AM
|
|
Hepalink
|
4
|
Resverlogix Corp.
|
Mar 01, 2020 10:22PM
|
|
Hepalink
|
4
|
Resverlogix Corp.
|
Sep 17, 2020 07:09PM
|
|
https://themarkether...
|
4
|
Resverlogix Corp.
|
Feb 22, 2022 03:42PM
|
|
Re: Can the Experts on this Forum tell us if this is credible?
|
4
|
Resverlogix Corp.
|
Mar 21, 2020 02:36PM
|
|
Hepalink
|
4
|
Resverlogix Corp.
|
Jun 13, 2022 08:52AM
|
|
Re: DM Interview w Jane King (Innovators) Apr 7 - COVID 19
|
4
|
Resverlogix Corp.
|
Apr 08, 2020 09:59PM
|
|
https://finance.yaho...
|
5
|
Resverlogix Corp.
|
Mar 07, 2022 09:23AM
|
|
Extension
|
5
|
Resverlogix Corp.
|
Jul 22, 2020 07:10AM
|
|
Re: A few thoughts
|
5
|
Resverlogix Corp.
|
Nov 16, 2019 02:34PM
|
|
Re: So BETonMACE failed the primary endpoint. What's next?
|
6
|
Resverlogix Corp.
|
Sep 30, 2019 05:35PM
|
|
debenture
|
6
|
Resverlogix Corp.
|
Mar 20, 2023 07:57AM
|
|
Re: Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
7
|
Resverlogix Corp.
|
Feb 17, 2022 09:08AM
|
|
Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease
|
7
|
Resverlogix Corp.
|
Aug 22, 2022 07:30AM
|
|
Re: COVID 19 / varients
|
8
|
Resverlogix Corp.
|
Apr 10, 2022 05:09PM
|
|
Re: Welcome to the RVX Hub on Agoracom
|
8
|
Resverlogix Corp.
|
Jun 25, 2019 09:04PM
|
